Physician profile
Benjamin Miller
NPI 1972894079
$22,640.24
in general payments reported to CMS, 2019-2025
14 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $368 · 2021: $4,533 · 2022: $1,574 · 2023: $960 · 2024: $4,691 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $2,805 · Travel and Lodging: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,168.13 |
| Food and Beverage | $2,804.88 |
| Travel and Lodging | $191.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,023.38 | 2023-2025 | General - Therapies, Spyglass Discover |
| Medtronic, INC. | $7,563.50 | 2022-2025 | Progrip, Ligasure, Signia |
| Intuitive Surgical, INC. | $5,125.14 | 2020-2025 | Da Vinci Surgical System |
| Davol INC. | $770.48 | 2022-2025 | |
| Tela Bio, INC. | $165.88 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $162.72 | 2022 | |
| Innovation Technologies INC | $156.82 | 2025 | Irrisept |
| Integra Lifesciences Corporation | $142.37 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Teleflex LLC | $131.71 | 2024 | Quikclot |
| Baxter Healthcare | $124.97 | 2024-2025 | Perclot, Tisseel |
| Aroa Biosurgery Incorporated | $107.27 | 2025 | |
| Ethicon US, LLC | $98.17 | 2025 | Echelon; Endopath, Ethicon |
| Becton, Dickinson and Company | $47.03 | 2024 | Phasix Mesh |
| Dilon Technologies, INC. | $20.80 | 2025 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.